Dannielle Kissel

Title: Innovator Spotlight: Dannielle Kissel and Her Valuable Contributions to Pain Management

Introduction:

Dannielle Kissel, a talented inventor based in Boothwyn, PA, has made significant strides in the field of pharmaceutical sciences. With a focus on addressing pain management, she holds a patent that showcases her innovative approach to treatment.

Latest Patents:

Dannielle Kissel is credited with a patent titled "N-type calcium channel antagonists for the treatment of pain." This invention outlines compounds that are effective for the treatment of pain, adhering to a specific structural diagram. The details of the patent include various groups denoted as R, A, and D, along with the pharmaceutical compositions and treatment methods utilizing these compounds.

Career Highlights:

Kissel currently works with AstraZeneca, a global biopharmaceutical company known for its commitment to innovation in healthcare. Her work in the laboratory has contributed to advancements in pain treatment methodologies, reflecting her dedication to improving patient care.

Collaborations:

Throughout her career, Dannielle has collaborated with esteemed colleagues such as Glen E. Ernst and Marc Chapdelaine. These partnerships have allowed for a synergistic approach to research and development, culminating in achievements that enhance the pharmaceutical landscape.

Conclusion:

Dannielle Kissel exemplifies the spirit of innovation in the medical field. Through her patent and collaborative efforts at AstraZeneca, she continues to make a profound impact on pain management therapies. Her work not only highlights her inventiveness but also underscores the importance of collaboration in achieving groundbreaking advancements.